Figures & data
Figure 1 Subject selection.
Abbreviations: GLM-IV, golimumab intravenous; IFX, infliximab; RA, rheumatoid arthritis.
![Figure 1 Subject selection.](/cms/asset/4377265e-a127-417f-8419-fd9c92449aba/dceo_a_12191891_f0001_c.jpg)
Table 1 Demographic characteristics of patients prior to matching
Table 2 Clinical characteristics of patients prior to matching
Table 3 Demographic characteristics of matched patients
Table 4 Clinical characteristics of matched patients
Table 5 Treatment patterns and infusion patterns
Figure 2 Distribution of maintenance infusions.
Abbreviations: GLM-IV, golimumab intravenous; IFX, infliximab.
![Figure 2 Distribution of maintenance infusions.](/cms/asset/da1de7df-39ac-4598-81ae-a575d83e1578/dceo_a_12191891_f0002_c.jpg)
Table 6 Drug and infusion expenditures